Justin Holland

Justin Holland

Executive Director, UK Analytical, Analytical Development

Guest Expert
About

Justin Holland has over 20 years of experience in pharmaceutical testing to support all phases of drug product development from pre-clinical through to commercial release. He joined the company in 2009 and oversees the analytical development and quality control teams at the Nottingham site primarily supporting the development of early phase drug products for Phase I clinical trials. 

His expertise includes working with poorly soluble molecules, modified release formulations and paediatric drug products and the associated testing.  

Justin holds a MChem degree in Chemistry from the Nottingham Trent University.

Quotient Sciences Translational Pharmaceutics
Translational Pharmaceutics, Drug Product Optimization, First-in-Human, Human ADME

Translational Pharmaceutics® Integrated Drug Development Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Read More